INFANRIX HEXA VACCINE
Product details
Registration number: SIN12288P
Classification: Prescription Only
Active ingredients:
- DIPHTHERIA TOXOID
- FILAMENTOUS HAEMAGGLUTININ
- HEPATITIS B SURFACE ANTIGEN (PURIFIED)
- HIB PURIFIED CAPSULAR POLYSACCHARIDE BOUND TO TETANUS TOXOID
- PERTACTIN (69 kDa OMP)
- PERTUSSIS TOXOID
- POLIOVIRUS TYPE 1 (INACTIVATED)
- POLIOVIRUS TYPE 2 (INACTIVATED)
- POLIOVIRUS TYPE 3 (INACTIVATED)
- TETANUS TOXOID
Strength:
- min 30 iu/0.5 ml
- 25 mcg/0.5 ml
- 10 mcg/0.5 ml
- 10 mcg/0.5 ml
- 8 mcg/0.5 ml
- 25 mcg/0.5 ml
- 40 du/0.5 ml
- 8 du/0.5 ml
- 32 du/0.5 ml
- min 40 iu/0.5 ml
Dosage form: INJECTION
Route: INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07CA09
HSA approval date: 7 May 2003
Manufacturer(s):
- GLAXOSMITHKLINE BIOLOGICALS SA
- GlaxoSmithKline Biologicals
- GSK Biologicals SA
Manufacturing country/countries: BELGIUM; FRANCE
What are the HSA registration number and classification for INFANRIX HEXA VACCINE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12288P
Classification: Prescription Only
What active ingredients and strength are recorded for INFANRIX HEXA VACCINE?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- DIPHTHERIA TOXOID
- FILAMENTOUS HAEMAGGLUTININ
- HEPATITIS B SURFACE ANTIGEN (PURIFIED)
- HIB PURIFIED CAPSULAR POLYSACCHARIDE BOUND TO TETANUS TOXOID
- PERTACTIN (69 kDa OMP)
- PERTUSSIS TOXOID
- POLIOVIRUS TYPE 1 (INACTIVATED)
- POLIOVIRUS TYPE 2 (INACTIVATED)
- POLIOVIRUS TYPE 3 (INACTIVATED)
- TETANUS TOXOID
Strength:
- min 30 iu/0.5 ml
- 25 mcg/0.5 ml
- 10 mcg/0.5 ml
- 10 mcg/0.5 ml
- 8 mcg/0.5 ml
- 25 mcg/0.5 ml
- 40 du/0.5 ml
- 8 du/0.5 ml
- 32 du/0.5 ml
- min 40 iu/0.5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for INFANRIX HEXA VACCINE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAMUSCULAR
Who is the recorded registrant for INFANRIX HEXA VACCINE?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for INFANRIX HEXA VACCINE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GLAXOSMITHKLINE BIOLOGICALS SA
- GlaxoSmithKline Biologicals
- GSK Biologicals SA
Manufacturing country/countries: BELGIUM; FRANCE
Where can I look up INFANRIX HEXA VACCINE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12288P or the exact product name INFANRIX HEXA VACCINE. The general register link does not preselect this product.
What are the source dates for this INFANRIX HEXA VACCINE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this INFANRIX HEXA VACCINE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12288P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)